Connect with us

Hi, what are you looking for?

Stock

23andMe considers selling its telehealth unit Lemonaid

Investing.com — Genetic testing firm 23andMe is reportedly considering the sale of its telehealth division, Lemonaid Health, according to Business Insider. The company, which has faced financial difficulties, originally acquired the virtual care startup in 2021 for $400 million in a cash and stock deal.

The stock value of 23andMe has seen a significant drop following a data breach in 2023 that exposed numerous customer accounts. The potential sale of Lemonaid Health appears to be part of the company’s strategy to navigate its current financial situation.

When 23andMe first purchased Lemonaid, it expressed an intention to offer personalized telemedicine care, using its genetic data collection to inform this care. However, it remains unclear how advanced the company’s efforts to sell Lemonaid Health are at this stage, as 23andMe has not responded to multiple requests for comment.

Lemonaid Health’s potential buyer remains unknown as the company has not disclosed any further details about this possible sale.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

This post appeared first on investing.com

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    You May Also Like

    Investing

    Newmont (NYSE: NEM) reported mixed financial results even as the price of gold approached its all-time high. In all, the company’s earnings per share...

    Investing

    Fisker (NYSE: FSR) stock price has been one of the best-performing electric vehicle (EV) stocks this week even as Tesla slumped. The shares jumped...

    Investing

    The Fox Corporation (NASDAQ: FOX) stock price has been under pressure as investors come to terms with the abrupt firing of Tucker Carlson. The...

    Investing

    NatWest (LON: NWG) share price rose sharply, helped by the strong results from Barclays. The stock jumped to a high of 274.8p, which was...




    Disclaimer: Oldamericanbroker.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the-company.


    Copyright © 2025 Oldamericanbroker.com